DIGITAL PATHOLOGY MARKET ANALYSIS

Digital Pathology Market, by Product Type (Image Analysis Software, Scanner {Bright Field Scanner, Fluorescence Scanner}, Services {Installation & Integration, Maintenance Services, Consulting Services}), by Therapeutic Area (Oncology, Hematology, Autoimmune Disorder, Dermatology and Others), by Technology (Immunohistochemistry, ISH & FISH, Immunofluorescence and others) End User (Pharmaceutical & Biotechnology Companies, Diagnostic Labs, Hospital Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : May 2023
Code : CMI379
Pages :240
Formats :
Excel and PDF
Industry : Medical Devices

Market News

Global Digital Pathology Market: Key Developments

In September 2022, Scopio Labs, a company advancing digital microscopy, launched the Full-Field Bone Marrow Aspirate (FF-BMA) application platform. This platform is the first to allow a complete digital workflow for bone marrow aspirate scanning and analysis. The highresolution full-field imaging and AI-driven decision support system from Scopio bring hematopathology one step closer to the much-needed digital transformation.

On October 18, 2022, GE Healthcare, a manufacturing company, and Tribun Health, a software company, announced a partnership with the goal of delivering departmental digital pathology solutions that give healthcare professionals a more comprehensive understanding of patient records. The alliance intends to bring a data management solution by interfacing Tribun’s Health Suite data into GE Healthcare’s solution, such as GE Healthcare’s vendor neutral archive, Edison Datalogue.

In April 2022, Scopio Labs, a company advancing digital microscopy, announced the launch and CE Mark (Conformité Européenne) approval of X100 Full Field Peripheral Blood Smear (Full Field PBS) all-digital morphology analysis platform, which is the first digital microscope that allows remote consultation and includes a computer-vision based decision support system, advancing manual microscopy into the digital age.

In May 2022, OptraSCAN India Private Limited, a company that provides the digital pathology solutions, announced that its digital pathology scanner OS-SiA had been granted U.S. patent-No 2020/0334814 A1 by the United States Patent and Trademark Office. With its built-in intelligence, OS-SiA can simultaneously scan, index, and analyze abnormal samples. The end user will benefit from being able to overlay the results of the analysis over the entire slide image that has been scanned.